Inhibition of human breast cancer cell (McF-7) growth in vitro by the somatostatin analog sms 201-995: Effects on cell cycle parameters and apoptotic cell death

Endocrinology

Volumn 129, Issue 5, 1991, Pages 2555-2562

  Pagliacci, Maria Cristina ^a   Tognellini, Rita ^a   Grignani, Fausto ^a   Nicoletti, Ildo ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

OCTREOTIDE;

APOPTOSIS; ARTICLE; BREAST CANCER; CELL CULTURE; CELL DEATH; CELL GROWTH; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL;

BREAST NEOPLASMS; CELL CYCLE; CELL DEATH; FLOW CYTOMETRY; HUMAN; OCTREOTIDE; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED;

EID: 0025719564     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/endo-129-5-2555     Document Type: Article

References (38)

1. Redding TW, Schally AV 1984 Inhibition of growth of pancreatic carcinomas in animal models by analogs of hypothalamic hormones. Proc Natl Acad Sci USA 81:248-252
2. Lamberts SWJ, Reubi JC, Uitterlinden P, Zuiderwijk P, van den Werff P, van Hal P 1986 Studies on the mechanism of action of the inhibitory effect of somatostatin analog SMS 201-995 on the growth of the prolactin/adrenocorticotropin-secreting pituitary tumor 7315a. Endocrinology 118:2188-2194
3. Viguerie N, Tahirijouti N, Ayral AM, Cambillau C, Scemama JL, Bastie MJ, Knuthsen S, Esteve JP, Pradayrol L, Susini C, Vaysse N 1989 Direct inhibitory effects of a somatostatin analog SMS 201-995 on Ar4-2J cell proliferation via pertussis toxin-sensitive guanosine triphosphate-binding protein-independent mechanism. Endocrinology 124:1017-1025
4. Setyono-Han B, Henkelman MS, Foekens JA, Klijn JGM 1987 Direct inhibitory effects of somatostatin (analogues) on the growth of human breast cancer cells. Cancer Res 47:1566-1570
5. Reubi JC, Maurer R, von Werder K, Torhorst J, Klijn JGM, Lamberts SWJ 1987 Somatostatin receptors in human endocrine tumors. Cancer Res 47:551-558
6. Reubi JC 1988 Identification of somatostatin receptors in human tumors. Triangle 27:179-188
7. Schally AV 1988 Oncological applications of somatostatin analogues. Cancer Res 48:6977-6985
8. Reubi JC, Torhorst J 1989 Relationship between somatostatin-, EGF- and steroid-hormone-receptors in breast cancer. Cancer 64:1254-1260
9. Lamberts SWJ, Uitterlinden P, Verschoor L, van Dongen KJ, Del Pozo E 1985 Long-term treatment of acromegaly with the somatostatin analog SMS 201-995. N Engl J Med 313:1576-1580
10. Furlanetto RW, Di Carlo JN 1984 Somatomedin C receptors and growth effects in human breast cells maintained in long-term tissue culture. Cancer Res 44:2122-2128
11. Bauer W, Briner U, Doepfner W, Haller R, Huguenin R, Marbach P, Petcher TJ, Pless J 1982 SMS 201-995: A very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci 31:1133-1140
12. Page M, Bejaoui N, Cinq-Mars B, Lemieux P 1988 Optimization of the tetrazolium-based colorimetric assay for the measurement of cell number and cytotoxicity. Int J Immunopharmacol 10:785-793
13. Pelicci G, Pagliacci MC, Lanfrancone L, Pelicci PG, Grignani F, Nicoletti I 1990 Inhibitory effect of the somatostatin analogue octreotide (SMS 201-995) on rat pituitary tumor cells (GH3) proliferation “in vitro.” J Endocrinol Invest 13:657-662
14. Fried J, Perez AG, Clarkson BD 1978 Rapid hypotonic method for flow cytofluorometry of monolayer cell cultures. Some pitfalls in staining and data analysis. J Histochem Cytochem 26:921-933
15. Dolbeare F, Gratzner H, Pallavicini MG, Gray JW 1983 Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine. Proc Natl Acad Sci USA 80:5573-5577
16. Dean PN 1980 A simplified method of DNA distribution analysis. Cell Tissue Kinet 13:299-308
17. Dean PN 1987 Data analysis in cell kinetics research. In: Gray JW, Darzynkiewicz A (eds) Techniques in Cell Cycle Analysis. Humana Press, Clifton, p 207
18. Ojeda F, Guarda MJ, Maldonado C, Folch U 1990 Protein Kinase-C involvement in thymocyte apoptosis induced by hydrocortisone. Cell Immunol 125:535-539
19. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C 1991 A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139:271-279
20. Wyllie AH, Kerr JFR, Currie AR 1980 Cell death: The significance of apoptosis. Int Rev Cytol 68:251-264
21. Wyllie AH, Morris RG, Smith AL, Dunlop D 1984 Chromatin cleavage in apoptosis: Association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol 142:67-77
22. Cohen JJ, Duke RC 1984 Glucocorticoid activation of a calciumdependent endonuclease in thymocyte nuclei leads to cell death. J Immunol 132:38-42
23. Baserga R 1989 Measuring parameters of growth. In: Baserga R (ed) Cell Growth and Division: A Practical Approach. IRL Press, Oxford, p 1-16
24. Scambia G, Panici PB, Baiocchi G, Perrone L, Iacobelli S, Mancuso S 1988 Antiproliferative effects of somatostatin and the somatostatin analog SMS 201-995 on three human breast cancer cell lines. J Cancer Res Clin Oncol 114:306-308
25. Garcia R, Gupta MK 1989 Lack of direct inhibitory activity of somatostatin analog SMS 201-995 on the growth of human breast cancer cells (MCF-7). Proceedings of the Annual Meeting of the American Association for Cancer Research 30:1154 (Abstract)
26. Katzenellenbogen BS, Norman MJ, Eckert RL, Peltz SW, Mangel WF 1984 Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells. Cancer Res 44:112-119
27. Van der Burg B, Rutteman GR, Blankenstein MA, de Laat SW, van Zoelen EJJ 1988 Mitogenic stimulation of human breast cancer cells in a growth factor-defined medium: Synergistic action of insulin and estrogen. J Cell Physiol 134:101-108
28. Zakarija M, McKenzie JM 1990 Do thyroid growth-promoting immunoglobulins exist? J Clin Endocrinol Metab 70:308-310
29. Hartwell LH, Weinert TA 1989 Checkpoints: Controls that ensure the order of cell cycle events. Science 246:629-634
30. Lewin B 1990 Driving the cell cycle: M phase kinase, its partners, and substrates. Cell 61:743-752
31. Liebow C, Reilly C, Serrano M, Schally AV 1989 Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase. Proc Natl Acad Sci USA 86:2003-2007
32. Williams GT, Smith CA, Spooncer E, Dexter TN, Taylor DR 1990 Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature 343:76-79
33. Pincus DW, DiCicco-Bloom EM, Black IB 1990 Vasoactive intestinal peptide regulates mitosis, differentiation and survival of cultured sympathetic neuroblasts. Nature 343:564-567
34. Koury MJ, Bondurant MC 1990 Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science 248:378-381
35. English HF, Kyprianou N, Isaacs JT 1989 Relationship between DNA fragmentation and apoptosis in the programmed cell death in the rat prostate following castration. Prostate 15:233-250
36. Szende B, Zalatnai A, Schally AV 1988 Programmed cell death (apoptosis) in pancreatic cancers of hamsters after treatment with analogs of both luteinizing hormone-releasing hormone and somatostatin. Proc Natl Acad Sci USA 86:1643-1647
37. Szende B, Srkalovic G, Groot K, Lapis K, Schally AV 1990 Growth inhibition of mouse MXT mammary tumor by the luteinizing hormone-releasing hormone antagonist SB-75. J Natl Cancer Inst 82:513-517
38. Sorenson CM, Barry MA, Eastman A 1990 Analysis of events associated with cell cycle arrest at G2 phase and cell death induced by cisplatin. J Natl Cancer Inst 82:749-755